Gilead Sciences, Inc.

Matthew J Von Bargen

Lan Jiang

Hong Yang

Jiayao Li

Qiaoyin Wu

Ana Zurisadai Gonzalez Buenrostro

Hang Chu

Xiaochun Han

Anna E Hurtley

Gregg M Schwarzwalder

Jennifer R Zhang

Michael L Mitchell

Devan Naduthambi

Hongyan Guo

David W Lin

Suzanne M Szewczyk

Devleena M Shivakumar

Gregg M Schwarzwälder

The present disclosure relates generally to certain tricyclic compounds, pharmaceutical compositions comprising said compounds, and methods of making said compounds and pharmaceutical compositions. The compounds of the disclosure are useful in treating or preventing human immunodeficiency virus (HIV) infection.

Substituted pyridotriazine compounds and uses thereof

The present disclosure relates generally to compounds, of Formula I Also disclosed are pharmaceutical compositions comprising said compounds and methods of making said compounds. The compounds of the disclosure are useful in treating or preventing human immunodeficiency virus (HIV) infection.

Bridged tricyclic carbamoylpyridone compounds and uses thereof

The present disclosure relates generally to compounds, of Formula I: Also disclosed are pharmaceutical compositions comprising said compounds and methods of making said compounds. The compounds of the disclosure are useful in treating or preventing human immunodeficiency virus (HIV) infection.

Growing community of inventors

Redwood City, CA, United States of America

Matthew J Von Bargen